Interplay Between Systemic Inflammation and Markers of Insulin Resistance in Cardiovascular Prognosis After Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 4, 2007, Pages 324-330

  Biadi, Ombretta ^a,c   Potena, Luciano ^a,d   Fearon, William F ^a   Luikart, Helen I ^a   Yeung, Alan ^a   Ferrara, Rossella ^a   Hunt, Sharon A ^a   Mocarski, Edward S ^b   Valantine, Hannah A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL INJURY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RISK FACTOR;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROGNOSIS; TRIGLYCERIDES;

EID: 33947674226     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.01.020     Document Type: Article

References (28)

1. Hertz M.I., Mohacsi P.J., Taylor D.O., et al. The registry of the International Society for Heart and Lung Transplantation: introduction to the Twentieth Annual Reports-2003. J Heart Lung Transplant 22 (2003) 610-615
2. Costanzo M., Naftel D., Pritzker M., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744-753
3. Billingham M. Histopathology of graft coronary disease. J Heart Lung Transplant 11 (1992) s38-s44
4. Weis M., and Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96 (1997) 2069-2077
5. Valantine H., Rickenbacker P., Kemna M., et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study. Circulation 103 (2001) 2144-2152
6. Hognestad A., Endresen K., Wergeland R., et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 42 (2003) 477-482
7. Pethig K., Heublein B., Kutschka I., and Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 102 19 suppl 3 (2000) III233-III236
8. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100-2104
9. Labarrere C.A., Lee J.B., Nelson D.R., Al-Hassani M., Miller S.J., and Pitts D.E. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 360 (2002) 1462-1467
10. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
11. Potena L., Holweg C., Chin C., et al. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 82 (2006) 398-405
12. Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108 (2003) 48-53
13. Gao S.Z., Alderman E.L., Schroeder J.S., Silverman J.F., and Hunt S.A. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12 (1988) 334-340
14. Clarke J., Anderson J., Carlquist J., et al. Do differing C-reactive protein assay methods impact cardiovascular risk assessment?. J Am Coll Cardiol 43 5 suppl A (2004) 288A
15. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
17. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
18. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
19. Blake G.J., and Ridker P.M. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 22 (2001) 349-352
20. Rifai N., and Ridker P.M. Proposed cardiovascular risk assessment algorithm using high-sensitivity c-reactive protein and lipid screening. Clin Chem 47 (2001) 28-30
21. Festa A., Hanley A.J., Tracy R.P., D'Agostino Jr. R., Haffner S.M., et al. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108 (2003) 1822-1830
22. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
23. Nakagomi A., Freedman S.B., and Geczy C.L. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 101 (2000) 1785-1791
24. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., and Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (1993) 513-520
25. Reynolds G.D., and Vance R.P. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 111 (1987) 265-269
26. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20 (2000) 2094-2099
27. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
28. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385